347 related articles for article (PubMed ID: 33312338)
21. Expression of H
Alvear-Arias JJ; Carrillo C; Villar JP; Garcia-Betancourt R; Peña-Pichicoi A; Fernandez A; Fernandez M; Carmona EM; Pupo A; Neely A; Alvarez O; Garate J; Barajas-Martinez H; Larsson HP; Lopez-Rodriguez A; Latorre R; Gonzalez C
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2104453119. PubMed ID: 35377790
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
23. Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation.
Mortimer PM; Mc Intyre SA; Thomas DC
Front Immunol; 2021; 12():733918. PubMed ID: 34539670
[TBL] [Abstract][Full Text] [Related]
24. High nuclear NADPH oxidase 4 expression levels are correlated with cancer development and poor prognosis in hepatocellular carcinoma.
Eun HS; Chun K; Song IS; Oh CH; Seong IO; Yeo MK; Kim KH
Pathology; 2019 Oct; 51(6):579-585. PubMed ID: 31443922
[TBL] [Abstract][Full Text] [Related]
25. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.
Kim E; Kim W; Lee S; Chun J; Kang J; Park G; Han I; Yang HJ; Youn H; Youn B
Sci Rep; 2017 Aug; 7(1):8923. PubMed ID: 28827764
[TBL] [Abstract][Full Text] [Related]
26. Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
Sag CM; Schnelle M; Zhang J; Murdoch CE; Kossmann S; Protti A; Santos CXC; Sawyer G; Zhang X; Mongue-Din H; Richards DA; Brewer AC; Prysyazhna O; Maier LS; Wenzel P; Eaton PJ; Shah AM
Circulation; 2017 May; 135(22):2163-2177. PubMed ID: 28298457
[TBL] [Abstract][Full Text] [Related]
27. Activation of adrenergic receptor in H9c2 cardiac myoblasts co-stimulates Nox2 and the derived ROS mediate the downstream responses.
Saleem N; Goswami SK
Mol Cell Biochem; 2017 Dec; 436(1-2):167-178. PubMed ID: 28593564
[TBL] [Abstract][Full Text] [Related]
28. Opportunistic Pathogen
Roberts JS; Atanasova KR; Lee J; Diamond G; Deguzman J; Hee Choi C; Yilmaz Ö
Front Cell Infect Microbiol; 2017; 7():291. PubMed ID: 28725637
[No Abstract] [Full Text] [Related]
29. Beyond bacterial killing: NADPH oxidase 2 is an immunomodulator.
Trevelin SC; Shah AM; Lombardi G
Immunol Lett; 2020 May; 221():39-48. PubMed ID: 32092360
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic computational modeling of the kinetics and regulation of NADPH oxidase 2 assembly and activation facilitating superoxide production.
Sadri S; Tomar N; Yang C; Audi SH; Cowley AW; Dash RK
Free Radic Res; 2020 Oct; 54(10):695-721. PubMed ID: 33059489
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma.
Wu S; Yang W; Zhang H; Ren Y; Fang Z; Yuan C; Yao Z
Technol Cancer Res Treat; 2019 Jan; 18():1533033819869949. PubMed ID: 31451090
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
[TBL] [Abstract][Full Text] [Related]
33. Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes.
Aurelius J; Martner A; Riise RE; Romero AI; Palmqvist L; Brune M; Hellstrand K; Thorén FB
J Leukoc Biol; 2013 Jan; 93(1):155-60. PubMed ID: 23072905
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
Hong SW; Park NS; Noh MH; Shim JA; Ahn BN; Kim YS; Kim D; Lee HK; Hur DY
Lung Cancer; 2017 Apr; 106():115-124. PubMed ID: 28285685
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
36. NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells.
Harel S; Mayaki D; Sanchez V; Hussain SNA
Vascul Pharmacol; 2017 May; 92():22-32. PubMed ID: 28351775
[TBL] [Abstract][Full Text] [Related]
37. miR-124-5p/NOX2 Axis Modulates the ROS Production and the Inflammatory Microenvironment to Protect Against the Cerebral I/R Injury.
Wu Y; Yao J; Feng K
Neurochem Res; 2020 Feb; 45(2):404-417. PubMed ID: 31950451
[TBL] [Abstract][Full Text] [Related]
38. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.
Neo SY; Yang Y; Record J; Ma R; Chen X; Chen Z; Tobin NP; Blake E; Seitz C; Thomas R; Wagner AK; Andersson J; de Boniface J; Bergh J; Murray S; Alici E; Childs R; Johansson M; Westerberg LS; Haglund F; Hartman J; Lundqvist A
J Clin Invest; 2020 Mar; 130(3):1185-1198. PubMed ID: 31770109
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of LOX-1
Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
[TBL] [Abstract][Full Text] [Related]
40. A Reduction in Intracellular Reactive Oxygen Species Due to a Mutation in NCF4 Promotes Autoimmune Arthritis in Mice.
Winter S; Hultqvist Hopkins M; Laulund F; Holmdahl R
Antioxid Redox Signal; 2016 Dec; 25(18):983-996. PubMed ID: 27231144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
